Explore key insights from ICON's Q4 2024 earnings call, including bookings growth, digital innovation, and strategic partnerships driving 2025 growth targets.
Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted)NEW YORK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback